Protamine Sulfate

Basic Information

Item Value
DrugBank ID DB09141
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 intestinal hypomagnesemia 1 KG + DL
2 Chuvash polycythemia KG + DL
3 ring chromosome 14 KG + DL
4 metaphyseal chondrodysplasia-retinitis pigmentosa syndrome KG + DL
5 intrinsic factor and r binder, combined congenital deficiency of KG + DL
6 neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination KG + DL
7 Stankiewicz-Isidor syndrome KG + DL
8 splenogonadal fusion-limb defects-micrognathia syndrome KG + DL
9 oculo-auriculo-vertebral spectrum KG + DL
10 Riley-Day syndrome KG + DL
11 pericardial effusion, chronic KG + DL
12 deoxyribose-5-phosphate aldolase deficiency KG + DL
13 spondyloepiphyseal dysplasia tarda with characteristic facies KG + DL
14 large congenital melanocytic nevus KG + DL
15 odontochondrodysplasia KG + DL
16 short chain acyl-CoA dehydrogenase deficiency KG + DL
17 mismatch repair cancer syndrome KG + DL
18 nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome KG + DL
19 craniofacial anomalies and anterior segment dysgenesis syndrome KG + DL
20 platelet storage pool deficiency KG + DL
21 ossification of the posterior longitudinal ligament of the spine KG + DL
22 neurodevelopmental disorder with central and peripheral motor dysfunction KG + DL
23 congenital absence/hypoplasia of fingers or thumb KG + DL
24 Pygmy KG + DL
25 hemolytic anemia due to erythrocyte adenosine deaminase overproduction KG + DL
26 platelet factor 3 deficiency KG + DL
27 WHIM syndrome KG + DL
28 short stature with nonspecific skeletal abnormalities KG + DL
29 autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency KG + DL
30 optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy KG + DL
31 chylomicronemia, familial, due to circulating inhibitor of lipoprotein lipase KG + DL
32 hypomyelination with brain stem and spinal cord involvement and leg spasticity KG + DL
33 familial isolated hypoparathyroidism due to agenesis of parathyroid gland KG + DL
34 polyglucosan body myopathy KG + DL
35 kapur-Toriello syndrome KG + DL
36 otodental syndrome KG + DL
37 granulosis rubra nasi KG + DL
38 hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 KG + DL
39 orotic aciduria KG + DL
40 autosomal dominant Robinow syndrome KG + DL
41 early-onset generalized dystonia KG + DL
42 FRAXE intellectual disability KG + DL
43 rhabdoid tumor predisposition syndrome KG + DL
44 Blount disease, infantile KG + DL
45 complement factor I deficiency KG + DL
46 thrombomodulin-related bleeding disorder KG + DL
47 Rajab interstitial lung disease with brain calcifications KG + DL
48 Say-field-Coldwell syndrome KG + DL
49 megalocornea (disease) KG + DL
50 BENTA disease KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.